REACTing is a collaborative network of major French research institutions, coordinated by Inserm (French National Institute of Health and Medical Research), which aims to optimise research capacity during epidemics & improve research preparedness in between epidemics through multi-disciplinary collaboration.

what we do



REACTing aims to forge a new dynamic to face health emergency situations by contributing to national health decisions and to international efforts to control emerging infectious threats. It covers a wide array of research fields in human and animal health: surveillance, public health, clinical research, mathematical modelling, diagnosis and pathogen characterization, social sciences and ethical and regulatory capacities.

REACTing is a multi-disciplinary project, coordinated by Inserm under the aegis of Aviesan, the French National Alliance for Life Sciences and Health. It brings together excellent research groups, institutions and laboratories in order to prepare and deal with unforeseeable emerging infectious threats.





REACTing's objectives are:

  • To improve research preparation in between epidemics
  • To stimulate, coordinate and facilitate the establishment of research projects during epidemics
  • To provide support in accessing research funding opportunities
  • To provide comprehensive information for decision-makers, the media and the public

REACTing wishes to strengthen interactions with low- and middle-income countries, particularly where French research platforms exist: Inserm/ANRS (National Agency for Research on AIDS and Hepatitis) research sites, IRD (French National Research Institute for Sustainable Development) research sites, The Institut Pasteur International Network, and others.

REACTing works in close collaboration with existing collaborative mechanisms focused on R&D during epidemics, most notably the World Health Organization (WHO) R&D Blueprint for action to prevent epidemics; the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R), a global network of major research funding organizations is expanding to facilitate an effective research response within 48 hours of an infectious disease outbreak; and the Coalition for Epidemic Preparedness Innovation (CEPI), a global non-profit alliance to finance and coordinate the development of new vaccines to prevent and contain infectious disease epidemics is operational.